Article
Although the mandatory compliance date for implementation is October 1, 2013, you'll need to accomplish much between now and then to make documentation and diagnosis reporting as seamless as possible.
Variants of unknown significance may adversely affect RARP outcomes
Key updates from the AUA/ASRM male infertility guideline amendment
Genetic testing in prostate cancer is increasing over time, data suggests
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
Study characterizes long-term impact of prostate cancer treatment
ALLO-316 shows encouraging CAR activity in advanced ccRCC